ArticleCancer gene therapy2008

Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan.

J Uchino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.